1. Total saponins of Bolbostemma paniculatum (maxim.) Franquet exert antitumor activity against MDA-MB-231 human breast cancer cells via inhibiting PI3K/Akt/mTOR pathway.
- Author
-
Dou JW, Shang RG, Lei XQ, Li KL, Guo ZZ, Ye K, Yang XJ, Li YW, Zhou YY, Yao J, and Huang Q
- Subjects
- Breast Neoplasms drug therapy, Breast Neoplasms genetics, Cell Line, Tumor, Female, Humans, Phosphatidylinositol 3-Kinases genetics, Proto-Oncogene Proteins c-akt genetics, Signal Transduction drug effects, TOR Serine-Threonine Kinases genetics, Antineoplastic Agents, Phytogenic pharmacology, Breast Neoplasms metabolism, Cucurbitaceae chemistry, Phosphatidylinositol 3-Kinases metabolism, Plant Extracts pharmacology, Proto-Oncogene Proteins c-akt metabolism, Saponins pharmacology, TOR Serine-Threonine Kinases metabolism
- Abstract
Background: The aim of the present study was to examine the effects of the Bolbostemma paniculatum (Maxim.) Franquet (BP) active compound, BP total saponins (BPTS), on MDA-MB-231 cells, and investigate the underlying mechanism regarding BPTS-mediated attenuation of the PI3K/Akt/mTOR pathway., Methods: The effect of BPTS on cytotoxicity, induction of apoptosis and migration on MDA-MB-231 cells at three different concentrations was investigated. A CCK-8 assay, wound-healing assay and flow cytometry were used to demonstrate the effects of BPTS. Additionally, expression of the primary members of the PI3K/Akt/mTOR signaling pathway was assessed using western blotting. To verify the underlying mechanisms, a PI3K inhibitor and an mTOR inhibitor were used., Results: BPTS inhibited proliferation of MDA-MB-231 cells with an IC
50 value of 10 μg/mL at 48 h. BPTS inhibited migration of MDA-MB-231 cells, and the western blot results demonstrated that BPTS reduced p-PI3K, p-Akt and p-mTOR protein expression levels in MDA-MB-231 cells. Additionally, the results were confirmed using a PI3K inhibitor and an mTOR inhibitor. BPTS decreased proliferation and migration of MDA-MB-231 cells possibly through inhibiting the PI3K/Akt/mTOR signaling pathway., Conclusions: The results highlight the therapeutic potential of BPTS for treating patients with triple-negative breast cancer.- Published
- 2019
- Full Text
- View/download PDF